【摘 要】
:
Introduction External beam radiation (EBRT) and 125I seed continuous low dose rate radiation (CLDR)were used to treat patients with lung cancer.The reasons for the improved therapy of CLDR were not fu
【机 构】
:
Department of Radiation Oncology, Peking University Third Hospital, Beijing 100191, P.R.China
【出 处】
:
北京大学医学部近距离放疗研究中心成立大会暨北京大学第三届国际放射肿瘤学术论坛
论文部分内容阅读
Introduction External beam radiation (EBRT) and 125I seed continuous low dose rate radiation (CLDR)were used to treat patients with lung cancer.The reasons for the improved therapy of CLDR were not fully understood.We herein investigated the different direct effects of EBRT and CLDR on lung cancer cells and its related mechanisms.Methods A549 cells were exposed to different doses of EBRT and CLDR,respectively.6-MV X-ray linear accelerator was used for EBRT and 125I seeds were used for CLDR.Cell survival, death, cycle and apoptosis were detected.The related intracellular molecule alterations were determined by real-time PCR and western blotting.Results Significantly lower colony forming efficiency of A549 cells was observed after CLDR than EBRT.CLDR inhibited cell growth and induced apoptosis,G2/M arrest more efficiently than EBRT.Cyclin B1 levels were reduced by CLDR.P-H2AX (Ser139) and DNA-PKcs expression were significantly elevated in A549 cells after CLDR.Anti-apoptosis Bcl-2 protein levels in A549 ceils were significantly reduced and apoptosis-inducing Bax mRNA and protein levels were increased after CLDR.Conclusions CLDR was more efficient to inhibit A549 lung cancer cell growth than EBRT.Decreased cyclin B1 may mediate CLDR-induced G2/M arrest.The long-lasting p-H2AX activity indicates the enhanced DNA damage by CLDR.The significantly decreased Bcl-2/Bax ratio induced by CLDR may contribute to the increased cell death of A549.Thus, the improved inhibition of CLDR on lung cancer cell growth may be mediated, at least partially, by the decrease Bcl2/Bax ratio and cyclin B 1-related G2/M arrest.
其他文献
目的 利用图像引导设备研究颈部原发椎体肿瘤摆位误差及其对放疗计划靶区外放范围的影响.方法 回顾性分析我中心2012年3月1日至2013年4月28日共计治疗颈部原发肿瘤患者12例,应用Varian RapidArc Cone-Beam CT(CBCT)对所有入组肿瘤患者进行图像验证CBCT验证共计91次.其中,颈椎嗜酸性肉芽肿患者4例,行CBCT验证共21次;颈椎浆细胞瘤患者2例,行CBCT验证共1
Purpose Radiation pneumonitis is a common complication of thoracic radiation.Our clinical experience suggested that Pneumocystisjiroveci pneumonia (PCP) contributes significantly to the mortality rate
目的 对重组人p53腺病毒注射液(rAd-p53,今又生)结合放疗治疗晚期肝癌的疗效及安全性进行评价.方法 自2003年12月至2013年01月,采用重组人p53腺病毒制剂(Gendicine商品名:今又生)结合放疗共治疗不能手术的晚期软组织肝癌22例.其中,男15例,女7例,年龄段30~72岁,平均51.5±19.0岁.全部病例经病理证实为肝癌,其中原发性肝癌10例, 转移性肝癌12例.所有病例
目的 分析直肠癌根治术后复发模式,为直肠癌盆腔靶区勾画提供理论依据;评估直肠癌局部复发放化疗的疗效和预后相关因素.方法 对2006年4月至2011年12月在我科就诊的147例直肠癌根治术后盆腔复发的患者进行了回顾性分析,男性77例,女性70例,中位年龄58岁(37-80岁),其中T3-4/N+期患者占89% (131/147).27例有术前或术后盆腔放疗史,其中19例为术前放疗30Gy/10次,1
目的 比较容积调强调强(Rapid Arc)与固定野动态调强(dlMRT)两种调强放疗技术用于局部进展期直肠癌术前放疗的临床疗效和毒性反应.方法 回顾性分析了2007年9月-2012年7月我科收治的T3-4/N+的直肠癌术前放化疗患者234例,中位年龄54岁(21-87岁),男性158例,女性76例,178例(76%)患者为低位直肠癌(距肛缘< 5cm).病理类型:低分化腺癌28例,中分化腺癌19
目的 探讨重组人腺病毒p53 (rAd-p53)对不同p53-mdm2反馈环状态的宫颈癌细胞放射敏感性影响.方法 先采用Western blot法检测了两种宫颈癌细胞系(Siha细胞系和C33a细胞系)初始p53和mdm2状态,然后,以rAd-p53分别感染含野生型p53基因的宫颈癌细胞Siha和含突变型p53基因的宫颈癌细胞C33a,测定经rAd-p53处理后不同时间p53表达水平的变化.采用W
Purpose: To investigate the feasibility, efficiency, and delivery accuracy of volumetric modulated arc therapy with constant dose rate (VMAT-CDR) for whole pelvic radiotherapy of endometrial cancer.Ma
Purpose: To investigate the feasibility of volumetric modulated arc therapy with SmartArc (VMAT-S) for endometrial cancer to achieve equivalent plan quality with higher delivery efficiency, against in
Purpose: To investigate the feasibility and efficiency of electronic portal imaging device for dosimetric verification of intensity-modulated radiation therapy.Methods: 10 patients treated with intens
目的 探讨重组人p53腺病毒瘤内注射后p53基因和靶基因的表达.方法 选择2005年9月-2006年12月在我院接受重组人p53腺病毒制剂."今又生"(Gendicine)治疗和放疗的恶性肿瘤患者25例,在基因治疗前和治疗后48小时,通过鼻咽镜活检或在B超引导下穿刺活检获取肿瘤标本,每次取三份标本,一份标本用于检查病理,一份用于免疫组化检测P53,P21,Bax和VEGF蛋白;另一份则用于p53m